Psoriasis
Atopic Dermatitis
Wound Healing
Skin Grafting
Non-GLP Skin Toxicology
Stroke
Neurodegenerative Diseases (AD’s, PD’s)
Psychopharmacology
CNS-PK
Pulmonary Arterial Hypertension
Ischemia Reperfusion
Heart failures (HFpEF & HFrEF)
Gastrointestinal disorders
Metabolic disturbances
Regulatory food toxicology
ETAP-Lab is compliant with
About us
ETAP-Lab is an independent Contract Research Organization (CRO)
ETAP-Lab provides preclinical pharmacology and research services, as well as scientific expertise, to Pharmaceutical and Agro-Food industries. Our activity focuses on In Vivo models of pathologies and toxicology studies in rodents to support drug and nutraceutic R&D for our sponsors.
Since the foundation in 1991, ETAP-Lab’s Scientists have an in-depth expertise in pathology modeling with rodents. By respecting rodent chronobiology and natural behaviors, ETAP-Lab proposes research models with added translational value. All our models are customizable and original specific models can be set-up and validated on request.
Subscribe to our newsletter
Our News
-
IBD Research – ETAP-Labs and Kisolite Corp enter into partnership.
Better than any certification, at ETAP-Lab we believe that customer recognition is the ultimate goal. We're proud to announce our strategic partnership with Kisolite Corp, a leader in innovative therapeutic
-
Discover our latest NDD’s results at the NEUROSCIENCE 2024 in Chicago
📌ETAP-Lab's team will attend the upcoming NEUROSCIENCE 2024 from Saturday, October 5 to Wednesday, October 9, in Chicago (IL, USA), in McCormick Place Convention Center. That meeting is the World's Largest
-
Meet ETAP-Lab at NLSDays 2024 for Partnering Opportunities
ETAP-Lab will attend the upcoming NLSDays on next September 18 - 19, 2024, in Malmö, Sweden for partnering opportunities. We are delighted to participate for the first time to Nordic Life